Ostatní
Návod 
Repligen Corporation
RGEN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
8.4B
Obrat
1B
Zisk
0B
Aktiva
3B
Dluh
1B
ROE
0%
ROA
0%
PE
132
PS
9
Cena 1R
103-183
⌀ Cena
136.95
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
27-04-2026
Poslední dividenda
Profil
Repligen Corporation vyvíjí a komerčně využívá biotechnologické technologie a systémy pro použití v biologickém procesu výroby léčiv v Severní Americe, Evropě, Asii a Tichomoří a na mezinárodní úrovni. Nabízí ligandy proteinu A, které jsou vazebnými složkami chromatografických pryskyřic s afinitou proteinu A, a produkty růstového faktoru buněčných kultur. Mezi chromatografické produkty společnosti patří OPUS předbalené chromatografické kolony, které se používají při čištění biologie; a OPUS menší kolony, které se používají při screeningu vývoje procesu s vysokou propustností, validačních studiích virové clearance a při validaci chromatografických procesů s použitím stupnice. Nabízí také testovací soupravy ELISA a chromatografické pryskyřice pod značkou CaptivA. Kromě toho společnost poskytuje filtrační produkty, jako jsou systémy XCell Alternating Tangential Flow, které jsou filtračními zařízeními používanými při propustném a buněčném zpracování buněčných kultur; kazety TangenX s plochými deskami, které se používají při navazujících biologických procesech koncentrace a formulace léčiv; systémy KrosFlo pro filtraci tangenciálního toku a hloubkovou filtraci tangenciálního toku; laboratorní a procesní dialyzační produkty SpectraFlo a dynamické dialyzační systémy SpectraFlo a duté vlákno pro jedno použití. Dále poskytuje produkty procesní analýzy, jako jsou sklopné spektroskopické systémy pod značkami SoloVPE, FlowVPE a FlowVPX. Společnost prodává své produkty společnostem působícím v oblasti biologických věd, biofarmaceutických a diagnostických společností, laboratorním výzkumníkům a smluvním výrobním organizacím. Společnost Repligen Corporation uzavřela s firmou Navigo Proteins GmbH dohody o spolupráci na vývoji vícenásobných ligandů. Společnost Repligen Corporation byla založena v roce 1981 a sídlí ve Walthamu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
1778
Založení
1986-04-29
Podobné společnosti
$ 11.44
- $ 0.11
$ 145.13
+ $ 1.97
$ 17.74
- $ 0.27
$ 114.26
- $ 1.96
$ 306.69
+ $ 1.13
$ 120.02
- $ 3.67
$ 168.50
+ $ 0.45
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 738.3 | 738.3 | 634.4 | 638.8 | 801.5 | 670.5 | 366.3 | 270.2 | 194.0 | 141.2 | 104.5 | 83.5 | 63.5 | 68.2 | 62.3 | 27.3 | 21.0 | |
| Cost of Revenues | 362.4 | 390.6 | 359.8 | 323.5 | 345.8 | 279.3 | 156.6 | 119.1 | 86.0 | 67.1 | 47.1 | 35.3 | 28.0 | 25.2 | 27.2 | 7.1 | 5.5 | |
| Gross Profit | 375.9 | 347.6 | 274.6 | 315.2 | 455.7 | 391.3 | 209.6 | 151.1 | 108.1 | 74.2 | 57.4 | 48.3 | 35.5 | 43.0 | 35.1 | 20.2 | 15.5 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 197.9 | 188.8 | 182.4 | 169.2 | 167.5 | 154.9 | 158.8 | 153.2 | 155.7 | 141.2 | |
| Cost of Revenues | 104.5 | 88.3 | 91.2 | 78.4 | 128.7 | 77.4 | 85.5 | 76.4 | 88.1 | 104.6 | |
| Gross Profit | 93.4 | 100.5 | 91.1 | 90.8 | 38.8 | 77.5 | 73.3 | 76.8 | 67.6 | 36.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 42.7 | 43.9 | 34.3 | 20.2 | 19.5 | 15.8 | 8.7 | 7.4 | 5.7 | 5.6 | 7.3 | 10.5 | 12.5 | 14.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 218.1 | 215.8 | 183.9 | 119.6 | 95.6 | 66.3 | 51.5 | 30.9 | 24.7 | 17.2 | 12.7 | 13.2 | 8.0 | 7.1 | |
| Depreciation & Amortization | 92.3 | 78.7 | 86.6 | 68.6 | 51.0 | 38.4 | 27.1 | 20.9 | 15.8 | 10.5 | 5.3 | 4.6 | 4.0 | 3.1 | 3.5 | 1.7 | 1.4 | |
| Total Operating Expenses | 320.0 | 288.0 | 309.8 | 261.1 | 259.8 | 218.1 | 139.8 | 115.1 | 82.1 | 60.2 | 38.2 | 30.4 | 22.8 | 20.0 | 23.7 | 20.5 | 21.2 | |
| Operating Income | 55.9 | 59.6 | -35.1 | 54.6 | 133.6 | 133.5 | 42.5 | 14.9 | 26.0 | 14.0 | 16.0 | 13.8 | 10.7 | 22.9 | 11.1 | -0.4 | -5.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.3 | 10.6 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 57.5 | 55.5 | ||
| Depreciation & Amortization | 20.0 | 24.4 | 24.8 | 23.2 | 35.3 | 17.4 | 21.3 | 21.3 | 17.1 | 19.7 | ||
| Total Operating Expenses | 74.9 | 83.7 | 77.2 | 84.2 | 75.3 | 85.3 | 65.9 | 73.0 | 67.8 | 66.0 | ||
| Operating Income | 18.6 | 16.8 | 13.9 | 6.6 | -36.5 | -7.8 | 7.4 | 3.8 | -0.9 | 4.8 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 34.6 | 27.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 44.8 | 23.2 | 22.6 | 10.0 | 1.2 | 12.7 | 12.1 | 9.3 | 6.7 | 6.4 | 3.8 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Other Expense | 6.5 | 2.8 | 8.1 | 9.6 | 85.5 | 20.0 | 16.7 | 11.3 | 2.2 | -0.3 | -3.8 | -4.4 | -1.6 | 0.1 | -0.1 | 0.4 | 0.9 | |
| IBT | 62.4 | 62.4 | -27.0 | 64.1 | 219.1 | 153.5 | 59.2 | 26.2 | 21.4 | 7.2 | 11.7 | 13.4 | 11.1 | 23.0 | 11.3 | 0.0 | -4.9 | |
| Income Tax Expense | 13.5 | 13.5 | -1.5 | 22.6 | 33.2 | 25.3 | -0.7 | 4.7 | 4.8 | -21.1 | 0.0 | 4.1 | 3.0 | 6.9 | -2.9 | -0.3 | -0.8 | |
| Net Income | 48.9 | 48.9 | -25.5 | 41.6 | 186.0 | 128.3 | 59.9 | 21.4 | 16.6 | 28.4 | 11.7 | 9.3 | 8.2 | 16.1 | 14.2 | 0.0 | -4.1 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.8 | 13.9 | 6.6 | 7.3 | -0.4 | 0.0 | 0.0 | 9.0 | 6.0 | 6.7 | ||
| Interest Expense | 5.9 | 27.4 | 5.8 | 5.7 | 5.5 | 5.6 | 5.5 | 5.5 | 7.8 | 0.3 | ||
| Other Expense | 0.6 | 0.3 | 4.3 | 1.4 | -2.1 | 6.7 | 1.6 | -0.1 | -7.9 | 6.8 | ||
| IBT | 19.1 | 17.1 | 18.2 | 7.9 | -38.6 | -1.1 | 9.0 | 3.7 | -8.8 | 11.6 | ||
| Income Tax Expense | 5.8 | 2.2 | 3.3 | 2.1 | -4.7 | -0.5 | 3.3 | 0.4 | 16.7 | -6.5 | ||
| Net Income | 13.3 | 14.9 | 14.9 | 5.8 | -33.9 | -0.7 | 5.7 | 3.3 | -25.5 | 18.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.75 | $3.35 | $2.33 | $1.14 | $0.44 | $0.38 | $0.74 | $0.35 | $0.28 | $0.25 | $0.51 | $0.46 | $0.00 | $-0.13 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.74 | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 | $0.28 | $0.25 | $0.50 | $0.45 | $0.00 | $-0.13 | |
| Shares Outstanding | 56.5 | 56.2 | 55.9 | 55.7 | 55.5 | 55.0 | 52.6 | 48.3 | 43.8 | 38.2 | 33.6 | 32.9 | 32.5 | 31.7 | 30.9 | 30.8 | 30.8 | |
| Diluted Shares Outstanding | 56.5 | 56.6 | 55.9 | 56.4 | 57.5 | 57.3 | 53.9 | 49.2 | 45.5 | 39.2 | 34.1 | 33.6 | 33.3 | 32.4 | 31.3 | 30.8 | 30.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.46 | $0.33 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.46 | $0.32 | ||
| Shares Outstanding | 56.5 | 56.2 | 56.2 | 56.1 | 56.1 | 56.0 | 55.9 | 55.8 | 55.8 | 55.8 | ||
| Diluted Shares Outstanding | 56.5 | 56.5 | 56.5 | 56.6 | 56.1 | 56.9 | 56.4 | 56.5 | 55.8 | 56.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 809.1 | 757.4 | 751.3 | 523.5 | 603.8 | 717.3 | 528.4 | 193.8 | 173.8 | 141.8 | 73.4 | 62.0 | 39.8 | 29.2 | 14.2 | 12.5 | |
| Short Term Investments | 809.1 | 0.0 | 0.0 | 100.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 19.5 | 17.7 | 23.1 | 21.8 | 10.8 | 35.4 | 40.6 | |
| Total Cash & ST Investments | 809.1 | 757.4 | 751.3 | 623.8 | 603.8 | 717.3 | 528.4 | 193.8 | 173.8 | 141.8 | 73.4 | 62.0 | 61.6 | 40.1 | 49.6 | 53.1 | |
| Accounts Receivable | 123.2 | 134.1 | 124.2 | 116.2 | 117.4 | 71.4 | 43.7 | 35.8 | 27.7 | 16.1 | 11.4 | 8.1 | 12.0 | 13.4 | 3.8 | 2.9 | |
| Inventory | 190.5 | 143.0 | 202.3 | 238.3 | 184.5 | 95.0 | 54.8 | 42.3 | 39.0 | 24.7 | 18.0 | 12.4 | 11.8 | 11.1 | 2.0 | 2.2 | |
| Other Current Assets | 36.0 | 31.6 | 33.2 | 17.4 | 19.3 | 14.1 | 3.1 | 2.4 | 1.3 | 0.6 | 0.7 | 1.0 | 0.6 | 0.8 | 0.5 | 1.5 | |
| Total Current Assets | 1,158.9 | 1,066.0 | 1,111.0 | 998.1 | 931.7 | 902.4 | 641.8 | 275.7 | 242.8 | 184.2 | 103.3 | 80.9 | 86.4 | 66.2 | 55.8 | 59.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 748.7 | 708.9 | 697.2 | 757.4 | 784.0 | 809.1 | 780.6 | 751.3 | 630.8 | 603.7 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 748.7 | 708.9 | 697.2 | 757.4 | 784.0 | 809.1 | 780.6 | 751.3 | 630.8 | 603.7 | |
| Accounts Receivable | 149.0 | 157.0 | 147.4 | 134.1 | 129.0 | 123.2 | 115.8 | 124.2 | 106.2 | 120.3 | |
| Inventory | 160.3 | 155.9 | 153.1 | 143.0 | 182.5 | 190.5 | 198.0 | 202.3 | 211.4 | 240.9 | |
| Other Current Assets | 38.4 | 35.2 | 34.7 | 31.6 | 36.1 | 36.0 | 38.6 | 33.2 | 30.1 | 33.8 | |
| Total Current Assets | 1,096.5 | 1,056.9 | 1,032.5 | 1,066.0 | 1,131.6 | 1,158.9 | 1,133.0 | 1,111.0 | 978.5 | 998.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 336.0 | 333.1 | 323.0 | 315.7 | 226.5 | 92.0 | 74.2 | 32.2 | 22.4 | 15.0 | 13.8 | 14.5 | 12.5 | 10.0 | 2.2 | 3.1 | |
| Goodwill | 985.6 | 1,031.0 | 987.1 | 855.5 | 860.4 | 618.3 | 468.4 | 326.7 | 327.3 | 59.5 | 14.3 | 14.2 | 1.0 | 1.0 | 1.0 | 1.0 | |
| Intangible Assets | 379.8 | 397.9 | 400.5 | 353.7 | 337.3 | 287.1 | 212.6 | 135.4 | 144.8 | 29.8 | 12.8 | 14.6 | 6.2 | 7.2 | 1.2 | 1.4 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 3.6 | 12.2 | 9.9 | 11.9 | 6.0 | |
| Other Long-Term Assets | 0.9 | 0.9 | 1.3 | 0.8 | 0.6 | 0.6 | 0.2 | 0.2 | 6.2 | 0.5 | 0.5 | -4.5 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Total Long-Term Assets | 1,703.0 | 1,763.6 | 1,713.4 | 1,526.5 | 1,426.7 | 1,000.5 | 758.3 | 498.9 | 500.7 | 104.8 | 43.0 | 47.3 | 32.3 | 30.8 | 16.4 | 11.7 | |
| Total Assets | 2,861.9 | 2,829.7 | 2,824.4 | 2,524.7 | 2,358.4 | 1,902.9 | 1,400.1 | 139.5 | 120.4 | 288.9 | 146.2 | -65.4 | 118.6 | 97.0 | 72.3 | 71.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 313.1 | 321.2 | 325.2 | 333.1 | 329.9 | 336.0 | 340.3 | 323.0 | 319.7 | 324.6 | |
| Goodwill | 1,112.7 | 1,114.0 | 1,082.4 | 1,031.0 | 987.6 | 985.6 | 986.0 | 987.1 | 869.3 | 870.7 | |
| Intangible Assets | 395.4 | 406.2 | 409.2 | 397.9 | 380.8 | 379.8 | 388.1 | 400.5 | 343.7 | 351.7 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 5.1 | 2.6 | 2.1 | 0.9 | 0.7 | 0.9 | 1.0 | 1.3 | 1.4 | 1.7 | |
| Total Long-Term Assets | 1,827.2 | 1,844.8 | 1,819.7 | 1,763.6 | 1,699.1 | 1,703.0 | 1,716.3 | 1,713.4 | 1,535.7 | 1,550.4 | |
| Total Assets | 2,923.7 | 2,901.6 | 2,852.1 | 2,829.7 | 2,830.6 | 2,861.9 | 2,849.3 | 2,824.4 | 2,514.1 | 2,549.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 20.9 | 32.1 | 19.6 | 27.6 | 36.2 | 16.9 | 11.4 | 10.5 | 7.3 | 5.1 | 6.7 | 3.9 | 1.7 | 2.5 | 0.9 | 1.0 | |
| Short-Term Debt | 81.6 | 15.1 | 75.1 | 291.6 | 263.6 | 249.0 | 3.6 | 103.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 57.8 | 66.3 | 46.4 | 65.8 | 60.7 | 37.8 | 28.3 | 14.6 | 17.0 | 15.6 | 11.8 | 6.7 | 9.6 | 7.7 | 3.7 | 3.7 | |
| Current Liabilities | 174.3 | 126.8 | 158.2 | 404.2 | 375.3 | 319.0 | 48.3 | 129.8 | 25.2 | 21.1 | 18.8 | 10.7 | 11.3 | 10.8 | 4.6 | 4.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 29.4 | 25.6 | 26.9 | 32.1 | 21.4 | 20.9 | 18.7 | 19.6 | 19.0 | 23.8 | |
| Short-Term Debt | 19.3 | 16.0 | 15.2 | 15.1 | 12.2 | 81.6 | 79.3 | 75.1 | 6.6 | 5.8 | |
| Other Current Liabilities | 66.7 | 59.1 | 88.7 | 64.9 | 58.2 | 57.2 | 63.9 | 46.4 | 324.4 | 325.3 | |
| Current Liabilities | 131.1 | 123.0 | 152.0 | 126.8 | 108.4 | 174.3 | 178.3 | 158.2 | 363.4 | 373.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 517.7 | 671.1 | 636.7 | 131.4 | 102.5 | 26.4 | 259.8 | 103.5 | 99.3 | 95.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 143.5 | 160.7 | 132.2 | 138.3 | 110.8 | 31.7 | 30.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 36.3 | 22.8 | 40.5 | 23.0 | 33.5 | 27.0 | 29.9 | 25.1 | 25.2 | 0.0 | 0.0 | 0.0 | 184.8 | 2,557.4 | 0.0 | 0.0 | |
| Total Liabilities | 875.6 | 856.9 | 853.2 | 614.0 | 608.3 | 373.7 | 340.3 | 155.0 | 151.9 | 120.1 | 23.5 | 15.5 | 14.8 | 12.9 | 5.2 | 5.3 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 669.6 | 670.0 | 668.5 | 671.1 | 660.3 | 661.2 | 658.5 | 636.7 | 130.6 | 134.4 | |
| Capital Leases | 150.9 | 152.3 | 154.1 | 160.7 | 150.9 | 155.6 | 154.3 | 126.6 | 133.9 | 137.3 | |
| Def. Tax Liability | 20.1 | 23.3 | 24.1 | 22.8 | 33.7 | 36.3 | 38.2 | 40.5 | 14.0 | 21.9 | |
| Total Liabilities | 840.6 | 839.9 | 866.7 | 856.9 | 814.0 | 875.6 | 878.7 | 853.2 | 525.6 | 578.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Retained Earnings | 444.3 | 407.4 | 438.8 | 397.3 | 194.1 | 65.8 | 5.8 | -15.6 | -31.5 | -59.9 | -71.5 | -80.9 | -89.1 | -105.2 | -118.0 | -117.9 | |
| Comprehensive Income | -44.2 | -52.5 | -37.4 | -34.4 | -16.9 | 2.1 | -15.0 | -11.9 | -6.4 | -13.7 | -8.6 | -5.8 | 2.0 | 1.9 | -6.8 | -5.5 | |
| Total Common Equity | 1,986.4 | 1,972.7 | 1,971.2 | 397.3 | 1,750.1 | 65.8 | 5.8 | -15.6 | -31.5 | -59.9 | 122.7 | -80.9 | 103.9 | 84.1 | 67.1 | 66.1 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Retained Earnings | 443.0 | 428.1 | 413.2 | 407.4 | 441.2 | 444.3 | 440.9 | 438.8 | 464.3 | 446.2 | |
| Comprehensive Income | -4.1 | -1.7 | -47.8 | -52.5 | -34.6 | -44.2 | -42.7 | -37.4 | -43.6 | -37.2 | |
| Total Common Equity | 2,083.1 | 2,061.7 | 1,985.5 | 1,972.7 | 2,016.7 | 1,986.4 | 1,970.6 | 1,971.2 | 464.3 | 446.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 742.9 | 686.2 | 711.8 | 423.0 | 366.1 | 275.4 | 263.3 | 103.5 | 99.3 | 95.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,986.4 | 1,972.7 | 1,971.2 | 1,910.7 | 1,750.1 | 1,529.2 | 1,059.8 | -15.6 | -31.5 | 168.8 | 122.7 | -80.9 | 103.9 | 84.1 | 67.1 | 66.1 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,083.1 | 2,061.7 | 1,985.5 | 1,972.7 | 2,016.7 | 1,986.4 | 1,970.6 | 1,971.2 | 464.3 | 446.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.9 | 48.9 | -25.5 | 41.6 | 186.0 | 128.3 | 59.9 | 21.4 | 16.6 | 28.4 | 11.7 | 9.3 | 8.2 | 16.1 | 14.2 | 0.0 | -4.1 | |
| Depreciation & Amortization | 70.4 | 97.0 | 86.6 | 68.1 | 51.0 | 38.4 | 27.1 | 20.9 | 15.8 | 10.5 | 5.3 | 4.6 | 4.0 | 3.1 | 3.5 | 1.7 | 1.4 | |
| Stock-Based Compensation | 30.8 | 32.6 | 48.1 | 25.6 | 27.3 | 27.5 | 17.0 | 12.8 | 10.2 | 6.7 | 4.6 | 3.6 | 1.8 | 1.1 | 1.0 | 1.0 | 1.0 | |
| Change Working Capital | 63.8 | -50.9 | 60.9 | -8.6 | -63.8 | -102.1 | -48.6 | -1.1 | -14.1 | -7.5 | -15.5 | -6.5 | 2.0 | 2.8 | -2.4 | 0.6 | -0.8 | |
| Change In Accounts Receivable | 0.0 | -17.2 | -14.0 | -3.3 | -3.6 | -46.5 | -21.0 | -7.7 | -6.1 | -6.9 | -3.2 | -3.7 | -1.6 | -0.8 | -1.2 | -0.7 | 0.0 | |
| Change In Accounts Payable | -4.4 | -4.2 | 12.9 | -9.8 | -8.2 | 19.5 | 2.5 | 0.7 | 2.3 | 0.8 | -1.8 | 3.0 | 2.3 | -0.7 | 1.0 | -0.1 | -0.9 | |
| Change In Inventories | 54.0 | -14.9 | 56.9 | 41.0 | -57.2 | -89.8 | -29.3 | -9.3 | -4.0 | 0.6 | -6.2 | -6.1 | -0.9 | -0.6 | 2.7 | 0.2 | 0.2 | |
| Other Non-cash Items | 31.3 | -10.2 | 5.4 | -15.0 | -27.0 | 20.4 | 11.2 | 13.8 | 4.2 | 4.0 | 5.5 | 4.1 | 2.1 | 0.1 | 0.3 | 0.0 | 0.0 | |
| Cash from Operations | 155.2 | 0.0 | 0.0 | 113.9 | 172.1 | 119.0 | 62.6 | 67.2 | 32.8 | 17.5 | 7.5 | 15.1 | 18.4 | 25.9 | 13.4 | 3.2 | -2.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 13.3 | 14.9 | 14.9 | 5.8 | -33.9 | -0.7 | 3.3 | 3.3 | -25.5 | 18.2 | |
| Depreciation & Amortization | 24.6 | 34.3 | 24.8 | 32.3 | 22.5 | 21.5 | 16.8 | 21.3 | 17.1 | 19.7 | |
| Stock-Based Compensation | 8.0 | 0.0 | 8.4 | 0.0 | 0.0 | 0.0 | 9.2 | 0.0 | 6.5 | 6.4 | |
| Change Working Capital | -24.4 | 12.0 | -12.1 | -26.4 | 46.4 | 2.0 | 10.7 | 8.6 | 2.8 | 36.1 | |
| Change In Accounts Receivable | -9.9 | 7.9 | -5.2 | -9.9 | -9.4 | -3.4 | 0.0 | 6.7 | -11.6 | 12.9 | |
| Change In Accounts Payable | 0.9 | 3.2 | -1.6 | -6.7 | 11.1 | 0.2 | 2.2 | -0.6 | -1.2 | -4.7 | |
| Change In Inventories | -9.6 | -4.5 | 3.0 | -3.8 | 36.8 | 9.7 | 7.3 | 3.2 | 15.0 | 28.5 | |
| Other Non-cash Items | 1.8 | -9.9 | -5.9 | 4.5 | 16.7 | 27.0 | 4.0 | 12.6 | 16.1 | -33.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.1 | 39.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -35.9 | -23.5 | -25.7 | -36.2 | -133.3 | -71.3 | -26.3 | -23.2 | -14.0 | -5.5 | -4.3 | -2.6 | -5.6 | -4.6 | -1.3 | -0.5 | -0.6 | |
| Acquisitions | -158.5 | -70.3 | -54.8 | -186.6 | 0.0 | -149.9 | -175.0 | -182.2 | 0.0 | -112.8 | -44.6 | -27.6 | -21.2 | -29,208.8 | -43,214.5 | -0.3 | -1.8 | |
| Investments | 0.0 | -200.3 | 0.0 | 0.0 | -100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.7 | -20.2 | -27.5 | -42.5 | -39.1 | -84.3 | -47.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 102.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 19.6 | 23.4 | 27.6 | 34.8 | 29.2 | 43.2 | 83.7 | 59.3 | |
| Other Investing Activities | -2.5 | 0.0 | 0.0 | -2.7 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 27.6 | -0.3 | 29,208.8 | 43,214.5 | 0.0 | 0.0 | |
| Cash from Investing | -194.4 | 0.0 | 0.0 | -123.3 | -233.2 | -221.2 | -201.4 | -205.3 | -14.0 | -98.2 | -49.2 | 4.8 | -19.8 | -17.9 | 2.8 | -1.5 | 9.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -8.2 | -5.4 | -7.1 | -4.4 | -10.0 | -7.1 | -4.8 | -8.4 | -11.1 | -9.0 | |
| Acquisitions | -0.4 | 0.0 | -0.2 | -69.7 | -56.1 | 1.3 | 0.0 | 0.0 | -158.8 | 0.3 | |
| Investments | -200.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -169.9 | -8.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -282.9 | 0.0 | 0.0 | 290.1 | 0.0 | 0.0 | 0.0 | -115.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Debt Issued | 602.9 | 686.2 | -25.6 | 578.9 | 56.9 | 90.7 | 12.1 | 274.8 | 4.2 | 4.0 | 95.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Issuance of Common Stock | 2.4 | 0.0 | 0.0 | 0.0 | 3.7 | 83.0 | 297.8 | 320.7 | 0.0 | 129.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -23.3 | 0.0 | 0.0 | -14.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -18.7 | 0.0 | 0.0 | -26.7 | -17.0 | -82.0 | 8.1 | 279.1 | 3.4 | 0.6 | 112.1 | 0.8 | 1.7 | 2.5 | 1.2 | 0.0 | 0.1 | |
| Cash from Financing | 252.6 | 0.0 | 0.0 | 249.0 | -13.3 | 1.0 | 305.9 | 484.9 | 3.4 | 129.9 | 112.1 | 0.8 | 1.7 | 2.5 | 1.2 | -0.1 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 290.1 | 0.0 | |
| Debt Issued | 688.9 | 2.8 | 2.4 | -2.5 | 13.8 | -70.4 | 5.1 | 25.9 | 582.0 | -2.9 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.3 | |
| Repurchase of Common Stock | -13.7 | 0.0 | -0.7 | 0.0 | 0.0 | 0.0 | -1.2 | 0.0 | -7.1 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.3 | -0.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 268.1 | -0.8 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 205.5 | -191.3 | 6.0 | 227.9 | -80.4 | -113.5 | 179.9 | 343.6 | 20.1 | 51.5 | 68.1 | 18.7 | -4.5 | 10.6 | 18.0 | 1.7 | 7.5 | |
| Closing Cash Balance | 809.1 | 566.0 | 757.4 | 751.3 | 523.5 | 603.8 | 717.3 | 537.4 | 193.8 | 173.8 | 122.2 | 54.1 | 35.4 | 39.8 | 29.2 | 14.2 | 12.5 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -182.7 | 39.9 | 11.6 | -60.1 | -26.6 | -25.2 | 28.5 | 29.3 | 120.5 | 27.1 | |
| Closing Cash Balance | 566.0 | 748.7 | 708.9 | 697.2 | 757.4 | 784.0 | 809.1 | 780.6 | 751.3 | 630.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 119.3 | 93.9 | 142.5 | 74.9 | 38.7 | 47.7 | 36.3 | 44.1 | 18.7 | 12.0 | 3.2 | 12.4 | 12.8 | 21.3 | 12.2 | 2.7 | -3.0 | |
| Real Free Cash Flow | 88.4 | 61.3 | 94.4 | 49.4 | 11.4 | 20.2 | 19.3 | 31.2 | 8.5 | 5.3 | -1.4 | 8.8 | 11.0 | 20.2 | 11.2 | 1.7 | -4.1 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 17.0 | 42.7 | 21.0 | 10.6 | 32.2 | 42.2 | 34.8 | 36.3 | 17.9 | 30.2 | |
| Real Free Cash Flow | 9.1 | 42.7 | 12.6 | 10.6 | 32.2 | 42.2 | 25.6 | 36.3 | 11.5 | 23.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 131.6 | -117.1 | 1703.4 |
| P/S | 8.7 | 12.8 | 67.9 |
| P/B | 3.1 | 1.2 | 25.8 |
| P/FCF | 85.8 | 86.1 | 396.3 |
| Market cap | $8.4 | $6.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 13.8 % | 0 % |
| Debt to Income | 1408.9 % | 213.5 % | 0 % |
| Debt to Free cash flow | 918.7 % | 4.2 % | 0 % |
| Interest expense percentage | 80.2 % | 101.3 % | 38.7 % |
| Current ratio | 8.4 | 7.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 2.3 % | 13 % | 0 % |
| ROA | 1.7 % | 4.7 % | 0 % |
| CapEx to Revenue | 3.4 % | 6.1 % | 10.6 % |
| RaD to Revenue | 0 % | 13 % | 0 % |
| ROEM | 410,142.2 | 334378.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 52.3 % | 57.4 % | 79.8 % |
| Operating margin | 7.5 % | 13.1 % | 29.6 % |
| Net margin | 6.6 % | 11.3 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.4 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 56.5 mil | 43.7 mil |
| Employee count | 1.8 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
